La FDA aprueba el primer tratamiento farmacológico dirigido contra tumores pulmonares con mutaciones en el gen KRAS

by Revista Genética Médica

El pasado 28 de mayo, la Administración de Medicamentos y Alimentos de los Estados Unidos (FDA, por sus siglas en inglés) aprobó la primera terapia dirigida para cáncer de pulmón en pacientes con...

Read more

Drugs approved by the FDA in 2020 reflect continuing trend of structural innovation

by CAS, a division of the American Chemical Society

New drug innovation remained strong in 2020. The total of 53 drugs approved represented the second-highest number of approvals in more than two decades, a positive indicator of productivity in the pha...

Read more

EEUU autoriza el ensayo de un medicamento con células madre de cordón umbilical para tratar la artritis reumatoide

by Secuvita

La Administración de Alimentos y Medicamentos de los Estados Unidos (FDA) ha aprobado la investigación con un fármaco con células madre mesenquimales de cordón umbilical para tratar la artritis r...

Read more

Life cycle in process validation. Continued Process Verification

by Telstar

This article introduces the concept of life cycle applied to process validation and how this idea was already underlying the first FDA reports on the challenges that the pharmaceutical industry had to...

Read more

The FDA licenses Chemotargets CLARITY platform

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

Chemotargets -a global leader in the development of intelligence platforms and drug design prediction, headquartered in the Barcelona Science Park- has signed a license agreement for its CLARITY® pla...

Read more

NDMA | Ranitidine medicines

by Asphalion

In September 2019, the European Commission (EC) requested EMA to start a review of ranitidine medicines after tests showed that some of these products contained the impurity N-nitrosodimethylamine (ND...

Read more

Grifols announces collaboration with US Government for a treatment against Covid-19

by CataloniaBio

Grif​ols, a CataloniaBio & HealthTech member, has entered into a formal collaboration with the Food and Drug Administra​tion (FDA) and other public health agencies of United States to collect plas...

Read more

Approval review of pemigatinib for patients harbouring FGFR2 fusions

by OncoDNA

The FDA have granted priority approval review of pemigatinib for patients harbouring FGFR2 fusions, based on interim data from the phase II FIGHT-202 study showing ORR 36%

Read more

VHIO investigators establish ‘user-friendly’ criteria to capture hyperprogression in patients treated with immune checkpoint inhibitors

by VHIO

While cancer immunotherapy continues to show promise in improving outcomes for patients across several tumor types, we must collectively strive to potentiate and personalize this armory to successfull...

Read more

ANACONDA BIOMED S.L. secures €20 Million round of funding

by Anaconda BioMed

​Anaconda​ Biomed S.L., a medical technology company developing next-generation th​rombectomy systems for the treatment of ischemic stroke, has closed €20 million in new funding. The funding w...

Read more

IMMUNOTHERAPY: Risk of Immunotherapy Related Toxicity in Patients with Rheumatoid Arthritis

by OncoDNA

Patients with coexisting autoimmune disorders were generally excluded from checkpoint inhibitor (CPI) trials due to concerns over toxicity. A small cohort study suggests this patient group can safely ...

Read more

Minoryx Therapeutics receives FDA Orphan Drug Designation for leriglitazone in Friedreich’s Ataxia

by Minoryx Therapeutics

Leriglitazone (MIN-102) is a novel, brain penetrant, orally bioavailable and selective PPARγ agonist Second Orphan Drug Designation granted by the FDA for leriglitazone in addition to X-linked adr...

Read more
Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Highlight

Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

El Marañón investiga la eficacia de un...

by Hospital General Universitario Gregorio Marañón

El proyecto “Dabalvancina como tratamiento local para las complicaci...

Photos Stream